ZEPTIDE 7.5MG PREFILLED SYRINGE by FEROZSONS contains Tirzepatide, a prescription injectable medicine that works through two incretin hormone pathways: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1).
Tirzepatide helps influence blood-glucose regulation, appetite, food intake, and gastric emptying. Depending on the approved indication, it may be prescribed for type 2 diabetes management and/or chronic weight management in appropriate patients.
The 7.5MG strength is part of the gradual Tirzepatide dose-escalation schedule and is generally considered after the patient has used lower strengths, such as 5MG, for an appropriate period and tolerated treatment well. It should be used only according to a healthcare professional's prescribed treatment plan.
❄️ TEMPERATURE-SENSITIVE PRODUCT: ZEPTIDE 7.5MG PREFILLED SYRINGE requires appropriate storage and temperature-controlled transportation. This product is currently deliverable only in Lahore.
✔️ Supports Weight Management – Tirzepatide can help reduce appetite and food intake, supporting weight reduction alongside a balanced diet and regular physical activity.
✔️ Helps Improve Blood Sugar Control – Supports glucose-dependent insulin secretion and blood-glucose regulation in appropriate adults with type 2 diabetes.
✔️ Dual GIP + GLP-1 Action – Works through both GIP and GLP-1 receptor pathways to influence important metabolic processes.
✔️ Helps Regulate Appetite – Tirzepatide can influence appetite-related pathways and may reduce calorie intake.
✔️ Supports Feelings of Fullness – Its effects on appetite and gastric emptying may contribute to increased satiety.
✔️ Helps Manage Post-Meal Glucose – Its effects on gastric emptying and glucose-dependent insulin secretion contribute to blood-glucose regulation.
✔️ Once-Weekly Administration – Tirzepatide is generally administered once weekly.
✔️ 7.5MG Treatment Strength – A dose-escalation strength used after lower doses when clinically appropriate and tolerated.
🌟 Contains Tirzepatide – A dual GIP/GLP-1 receptor agonist used in appropriate patients for metabolic treatment.
⚖️ Weight Management Support – Helps regulate appetite and food intake as part of a medically supervised treatment plan.
🩸 Blood Glucose Support – Helps improve glycemic control in appropriate adults with type 2 diabetes.
💉 Prefilled Syringe Format – Convenient injectable format for prescribed subcutaneous administration.
📈 Dose-Escalation Strength – 7.5MG is generally reached after treatment with lower Tirzepatide strengths.
🏭 FEROZSONS – ZEPTIDE is supplied under the FEROZSONS brand.
📦 1 Unit Per Pack – Contains 1 prefilled syringe.
❄️ Temperature Sensitive – Requires appropriate storage and careful transportation.
🚚 Lahore Delivery Only – Currently available for delivery only in Lahore.
✔️ Use ZEPTIDE exactly as prescribed by your healthcare professional.
✔️ Tirzepatide is generally administered once weekly.
✔️ The 7.5MG strength is generally considered after at least four weeks on the 5MG dose, when a higher dose is clinically appropriate.
✔️ Administer the injection subcutaneously according to the manufacturer's instructions.
✔️ Common injection sites include the abdomen, thigh, or upper arm.
✔️ Rotate injection sites regularly.
✔️ Tirzepatide can generally be administered with or without food.
⚠️ Do not increase your dose without your doctor's advice.
⚠️ Do not share the prefilled syringe with another person.
Tirzepatide is generally introduced gradually to help improve tolerability.
A commonly used dose-escalation pathway is:
2.5MG → 5MG → 7.5MG → 10MG → 12.5MG → 15MG
Weeks 1–4: 2.5MG once weekly
Weeks 5–8: 5MG once weekly
After at least 4 weeks on 5MG: The dose may be increased to 7.5MG once weekly if additional treatment is required and the current dose is tolerated.
Further increases may generally be made in 2.5MG increments after at least four weeks on the current dose.
⚠️ Do not automatically increase from 7.5MG to 10MG. Dose adjustments should be made by your healthcare professional based on your treatment response and tolerability.
Tirzepatide is a dual GIP and GLP-1 receptor agonist.
GIP activation contributes to glucose-dependent insulin secretion and influences metabolic processes associated with energy balance.
GLP-1 activation contributes to blood-glucose regulation, appetite control, and delayed gastric emptying.
Tirzepatide influences several important metabolic processes:
✔️ Blood-glucose regulation
✔️ Insulin response
✔️ Appetite
✔️ Food intake
✔️ Gastric emptying
✔️ Feelings of fullness
✔️ Body-weight management
ZEPTIDE 7.5MG PREFILLED SYRINGE contains Tirzepatide and may be prescribed as part of an ongoing treatment plan.
It may be used for:
✔️ Type 2 diabetes management
✔️ Chronic weight management, depending on the approved indication
✔️ Supporting improved blood-glucose control
✔️ Supporting appetite and calorie-intake management
✔️ Continuing Tirzepatide treatment after lower strengths
✔️ Supporting metabolic health alongside appropriate lifestyle measures
⚠️ Tirzepatide is not a treatment for type 1 diabetes and should not replace insulin when insulin therapy is required.
🚨 Prescription Medicine: Use ZEPTIDE only under the supervision of a qualified healthcare professional.
🚨 Thyroid C-Cell Tumors: Tirzepatide carries a warning based on thyroid C-cell tumors observed in animal studies. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2, according to applicable prescribing information.
🚨 Pancreatitis: Seek medical attention if severe or persistent abdominal pain occurs, particularly if it radiates toward the back.
🚨 Hypoglycemia: The risk of low blood sugar may increase when Tirzepatide is used with insulin or certain insulin-releasing medicines.
🚨 Gastrointestinal Effects: Nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion may occur.
🚨 Dehydration: Significant vomiting or diarrhea may cause dehydration and potentially affect kidney function.
🚨 Gallbladder Problems: Tirzepatide may be associated with gallbladder-related adverse effects.
🚨 Pregnancy: Discuss pregnancy planning with your healthcare professional. Tirzepatide should not be used for weight reduction during pregnancy.
🚨 Oral Medicines: Tirzepatide delays gastric emptying and may affect the absorption of certain oral medicines.
Possible side effects include:
✔️ Nausea
✔️ Diarrhea
✔️ Decreased appetite
✔️ Vomiting
✔️ Constipation
✔️ Abdominal discomfort
✔️ Indigestion
✔️ Injection-site reactions
✔️ Fatigue
✔️ Belching
✔️ Acid reflux
Gastrointestinal effects may be more noticeable after a dose increase.
🚨 Severe or persistent abdominal pain
🚨 Persistent vomiting or severe dehydration
🚨 Difficulty breathing or signs of a serious allergic reaction
🚨 Symptoms of severe hypoglycemia
🚨 Yellowing of the skin or eyes
🚨 Severe or persistent gastrointestinal symptoms
ZEPTIDE 7.5MG PREFILLED SYRINGE is a temperature-sensitive injectable medicine.
❄️ Store according to the manufacturer's recommended storage conditions.
🚫 Do not freeze the product.
🚫 Do not use the medicine if it has been frozen or exposed to inappropriate temperatures.
☀️ Protect the product from excessive heat and direct sunlight.
📦 Proper temperature-controlled handling is important during transportation.
🚚 Delivery: ZEPTIDE 7.5MG PREFILLED SYRINGE is currently available for delivery only in Lahore.
⭐⭐⭐⭐⭐ “I ordered ZEPTIDE 7.5MG from SuperCare Pharma and the ordering process was very smooth. The product was securely packed and delivered safely in Lahore.”
— Ahmed K., Lahore 📍
⭐⭐⭐⭐⭐ “Very satisfied with the service. The temperature-sensitive medicine was handled carefully and the delivery was professional.”
— Usman R., Lahore 📍
⭐⭐⭐⭐⭐ “The order was easy to place and arrived properly packed. Excellent experience with SuperCare Pharma.”
— Hassan M., Lahore 📍
ZEPTIDE 7.5MG PREFILLED SYRINGE by FEROZSONS provides Tirzepatide 7.5MG in a convenient prefilled syringe format.
The 7.5MG strength is generally reached after treatment with lower strengths and may be prescribed when additional treatment is required and the current dose is well tolerated.
Tirzepatide works through GIP and GLP-1 receptor pathways, influencing important metabolic processes associated with blood-glucose regulation, appetite, food intake, gastric emptying, and body-weight management.
❄️ Temperature Sensitive | Lahore Delivery Only
⚠️ Prescription medicine – use only under the supervision of a qualified healthcare professional.
✔️ ZEPTIDE contains Tirzepatide and may be prescribed for type 2 diabetes management and/or chronic weight management, depending on the approved indication.
✔️ No. Tirzepatide is generally started at 2.5MG once weekly and gradually increased. The 7.5MG strength is generally reached after treatment with lower doses.
✔️ Tirzepatide 7.5MG is generally administered once weekly. Follow the exact schedule prescribed by your healthcare professional.
✔️ Common side effects may include nausea, diarrhea, decreased appetite, vomiting, constipation, abdominal discomfort, and indigestion.
📢 ZEPTIDE 7.5MG PREFILLED SYRINGE by FEROZSONS is available through SuperCare Pharma, with temperature-sensitive delivery currently available only in Lahore.
🏆 Trusted Online Pharmacy in Pakistan – Convenient online access to medicines and healthcare products.
💊 Genuine Pharmaceutical Products – Quality medicines from established pharmaceutical brands.
❄️ Temperature-Sensitive Handling – Special care for temperature-sensitive injectable products.
📦 Secure Packaging – Products are carefully prepared for transportation.
🚚 Lahore Delivery – ZEPTIDE 7.5MG is currently available for delivery in Lahore.
💰 Competitive Prices – Convenient online shopping at competitive prices.
📞 Customer Support – Assistance for product and delivery queries.
Looking for ZEPTIDE 7.5MG PREFILLED SYRINGE (Tirzepatide)?
Order ZEPTIDE 7.5MG by FEROZSONS from SuperCare Pharma for convenient online ordering and temperature-sensitive delivery in Lahore.
💙 ZEPTIDE 7.5MG | Tirzepatide | FEROZSONS | Prefilled Syringe
❄️ Temperature Sensitive | Lahore Delivery Only
⚠️ Prescription medicine – use only under the supervision of a qualified healthcare professional.
